Literature DB >> 21964059

Clonal replacement among 19A Streptococcus pneumoniae in Massachusetts, prior to 13 valent conjugate vaccination.

W P Hanage1, C J Bishop, G M Lee, M Lipsitch, A Stevenson, S L Rifas-Shiman, S I Pelton, S S Huang, J A Finkelstein.   

Abstract

As part of an ongoing study of the response of the Streptococcus pneumoniae population to conjugate vaccination, we applied multi-locus sequence typing (MLST) to 291 isolates sampled from nasopharyngeal carriage in Massachusetts children. We found 94 distinct sequence types (STs), including 19 that had not been previously recorded, and a xpt allele containing a large insertion. Comparison with a similar sample collected in 2007 revealed no significant overall difference in the ST composition (p=0.51) suggesting that the population has reached a new equilibrium following the introduction of 7 valent vaccination in 2000. Within serotypes, a large and statistically significant increase (p=0.014 Fisher's Exact test) was noted in the prevalence of the major multiresistant clone ST 320, which is apparently outcompeting ST 199 among serotype 19A strains. This sample will be used as a baseline to study the future evolution of the pneumococcal population in Massachusetts following introduction of vaccines with higher valency.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21964059      PMCID: PMC3221484          DOI: 10.1016/j.vaccine.2011.09.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era.

Authors:  William P Hanage; Susan S Huang; Marc Lipsitch; Cynthia J Bishop; Daniel Godoy; Stephen I Pelton; Richard Goldstein; Heather Huot; Jonathan A Finkelstein
Journal:  J Infect Dis       Date:  2006-12-27       Impact factor: 5.226

Review 2.  The rise and fall of bacterial clones: Streptococcus pneumoniae.

Authors:  Birgitta Henriques-Normark; Christel Blomberg; Jessica Dagerhamn; Patrick Bättig; Staffan Normark
Journal:  Nat Rev Microbiol       Date:  2008-11       Impact factor: 60.633

3.  Continued impact of pneumococcal conjugate vaccine on carriage in young children.

Authors:  Susan S Huang; Virginia L Hinrichsen; Abbie E Stevenson; Sheryl L Rifas-Shiman; Ken Kleinman; Stephen I Pelton; Marc Lipsitch; William P Hanage; Grace M Lee; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

4.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

Authors:  Tamara Pilishvili; Catherine Lexau; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Arthur Reingold; Ann Thomas; William Schaffner; Allen S Craig; Philip J Smith; Bernard W Beall; Cynthia G Whitney; Matthew R Moore
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

5.  Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Authors:  Lauri A Hicks; Lee H Harrison; Brendan Flannery; James L Hadler; William Schaffner; Allen S Craig; Delois Jackson; Ann Thomas; Bernard Beall; Ruth Lynfield; Arthur Reingold; Monica M Farley; Cynthia G Whitney
Journal:  J Infect Dis       Date:  2007-10-04       Impact factor: 5.226

6.  Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine.

Authors:  R Sá-Leão; S Nunes; A Brito-Avô; N Frazão; A S Simões; M I Crisóstomo; A C S Paulo; J Saldanha; I Santos-Sanches; H de Lencastre
Journal:  Clin Microbiol Infect       Date:  2009-04-23       Impact factor: 8.067

7.  Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.

Authors:  Stephen I Pelton; Heather Huot; Jonathan A Finkelstein; C J Bishop; Katherine K Hsu; Joan Kellenberg; Susan S Huang; Richard Goldstein; William P Hanage
Journal:  Pediatr Infect Dis J       Date:  2007-06       Impact factor: 2.129

8.  Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related.

Authors:  Monica Moschioni; Claudio Donati; Alessandro Muzzi; Vega Masignani; Stefano Censini; William P Hanage; Cynthia J Bishop; Joice Neves Reis; Staffan Normark; Birgitta Henriques-Normark; Antonello Covacci; Rino Rappuoli; Michèle A Barocchi
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226

9.  Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae.

Authors:  Dylan R Pillai; Dea Shahinas; Alla Buzina; Remy A Pollock; Rachel Lau; Krishna Khairnar; Andrew Wong; David J Farrell; Karen Green; Allison McGeer; Donald E Low
Journal:  BMC Genomics       Date:  2009-12-30       Impact factor: 3.969

10.  Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Authors:  Angela B Brueggemann; Rekha Pai; Derrick W Crook; Bernard Beall
Journal:  PLoS Pathog       Date:  2007-11       Impact factor: 6.823

View more
  27 in total

1.  Comparative genomics of invasive Streptococcus pneumoniae CC320/271 serotype 19F/19A before the introduction of pneumococcal vaccine in India.

Authors:  Rosemol Varghese; Ayyanraj Neeravi; Jobin John Jacob; Karthick Vasudevan; Jones Lionel Kumar; Nithya Subramanian; Balaji Veeraraghavan
Journal:  Mol Biol Rep       Date:  2021-04-19       Impact factor: 2.316

2.  Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts.

Authors:  Grace M Lee; Ken Kleinman; Stephen I Pelton; William Hanage; Susan S Huang; Matthew Lakoma; Maya Dutta-Linn; Nicholas J Croucher; Abbie Stevenson; Jonathan A Finkelstein
Journal:  J Pediatric Infect Dis Soc       Date:  2013-10-03       Impact factor: 3.164

3.  Genetic analyses of penicillin binding protein determinants in multidrug-resistant Streptococcus pneumoniae serogroup 19 CC320/271 clone with high-level resistance to third-generation cephalosporins.

Authors:  Margaret Ip; Irene Ang; Veranja Liyanapathirana; Helen Ma; Raymond Lai
Journal:  Antimicrob Agents Chemother       Date:  2015-04-27       Impact factor: 5.191

Review 4.  Not So Simple After All: Bacteria, Their Population Genetics, and Recombination.

Authors:  William P Hanage
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

5.  Correlates of Nonrandom Patterns of Serotype Switching in Pneumococcus.

Authors:  Shreyas S Joshi; Mohammad A Al-Mamun; Daniel M Weinberger
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 5.226

Review 6.  Mechanisms of genome evolution of Streptococcus.

Authors:  Cheryl P Andam; William P Hanage
Journal:  Infect Genet Evol       Date:  2014-11-13       Impact factor: 3.342

7.  Prevalence of Parental Misconceptions About Antibiotic Use.

Authors:  Louise Elaine Vaz; Kenneth P Kleinman; Matthew D Lakoma; M Maya Dutta-Linn; Chelsea Nahill; James Hellinger; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2015-07-20       Impact factor: 7.124

8.  Stability of the pneumococcal population structure in Massachusetts as PCV13 was introduced.

Authors:  Qiuzhi Chang; Abbie E Stevenson; Nicholas J Croucher; Grace M Lee; Stephen I Pelton; Marc Lipsitch; Jonathan A Finkelstein; William P Hanage
Journal:  BMC Infect Dis       Date:  2015-02-18       Impact factor: 3.090

Review 9.  Mechanisms and impact of genetic recombination in the evolution of Streptococcus pneumoniae.

Authors:  Chrispin Chaguza; Jennifer E Cornick; Dean B Everett
Journal:  Comput Struct Biotechnol J       Date:  2015-04-08       Impact factor: 7.271

10.  Vaccination Drives Changes in Metabolic and Virulence Profiles of Streptococcus pneumoniae.

Authors:  Eleanor R Watkins; Bridget S Penman; José Lourenço; Caroline O Buckee; Martin C J Maiden; Sunetra Gupta
Journal:  PLoS Pathog       Date:  2015-07-16       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.